University of California San Francisco School of Medicine, San Francisco, California; the Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, and the Department of Health, Behavior & Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; and the Division of General Pediatrics and Adolescent Health, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.
Obstet Gynecol. 2020 Sep;136(3):576-581. doi: 10.1097/AOG.0000000000004002.
With the simultaneous rise in maternal opioid use disorder (OUD) and the incarceration of pregnant people in the United States, we must ensure that prisons and jails adequately address the health and well-being of incarcerated pregnant people with OUD. Despite long-established, clear, and evidence-based recommendations regarding the treatment of OUD during pregnancy, incarcerated pregnant people with OUD do not consistently receive medication treatment and are instead forced into opioid withdrawal. This inadequate care raises multiple concerns, including issues of justice and equity, considerations regarding the legal and ethical obligations of the provision of health care, and violations of the medical and legal rights of incarcerated people. We offer recommendations for improving care for this often-ignored group.
随着美国产妇阿片类药物使用障碍（OUD）的同时上升和孕妇被监禁，我们必须确保监狱和拘留所充分解决患有 OUD 的被监禁孕妇的健康和福祉问题。尽管针对怀孕期间治疗 OUD 有长期确立的、明确的和基于证据的建议，但患有 OUD 的被监禁孕妇并未始终接受药物治疗，而是被迫戒断阿片类药物。这种不充分的护理引起了多个问题的关注，包括司法和公平问题、考虑医疗保健提供的法律和道德义务问题，以及侵犯被监禁者的医疗和法律权利问题。我们为改善对这个经常被忽视的群体的护理提出了建议。
